+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astex Pharmaceuticals - logo

Astex Pharmaceuticals is a member of one of Japan's leading pharmaceutical companies, the Otsuka group. It focuses on developing small-molecule therapeutics with a focus on oncology and hematology. Its fragment-based drug discovery platform, Pyramid, has been successfully applied to therapeutic targets addressing a variety of disease areas. The company was formerly known as SuperGen Inc. and changed its name in September 2011. Astex was founded in 1991 and is headquartered in Dublin, California.

From
Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Caspases Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Caspases Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Mantle Cell Lymphoma Therapeutics Global Market Report 2024 - Product Thumbnail Image

Mantle Cell Lymphoma Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
T cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

T cell Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Neurofibrosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neurofibrosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Chronic lymphocytic leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic lymphocytic leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
From
Chondrosarcoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Chondrosarcoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 591 Pages
  • Global
From
Cyclin Dependent Kinase 2 - Pipeline Review, H2 2020 - Product Thumbnail Image

Cyclin Dependent Kinase 2 - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 95 Pages
  • Global
From
Oropharyngeal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Oropharyngeal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 724 Pages
  • Global
From
From
Peritoneal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Peritoneal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 1845 Pages
  • Global
From
Osteosarcoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteosarcoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 868 Pages
  • Global
From
From
E3 Ubiquitin Protein Ligase Mdm2 - Pipeline Review, H1 2020 - Product Thumbnail Image

E3 Ubiquitin Protein Ligase Mdm2 - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 101 Pages
  • Global
From
Loading Indicator